RESEARCH AND DEVELOPMENT OF ORAL CONTROLLED RELEASE DOSAGE FORMS

被引:0
作者
MOES, AJ
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:60 / 70
页数:11
相关论文
共 50 条
[41]   REPORT OF THE WORKSHOP ON - INVITRO AND INVIVO TESTING AND CORRELATION FOR ORAL CONTROLLED MODIFIED RELEASE DOSAGE FORMS [J].
SKELLY, JP ;
AMIDON, GL ;
BARR, WH ;
BENET, LZ ;
CARTER, JE ;
ROBINSON, JR ;
SHAH, VP ;
YACOBI, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 63 (02) :83-93
[42]   Solubility considerations and design of controlled release dosage forms [J].
Venkatesh, Gopi M. .
ACS Symposium Series, 2000, 752 :335-347
[43]   The pharmacoeconomic value of controlled-release dosage forms [J].
Saks, SR ;
Gardner, LB .
JOURNAL OF CONTROLLED RELEASE, 1997, 48 (2-3) :237-242
[44]   Controlled release dosage forms: From ground to space [J].
Colombo, P ;
Bettini, R ;
Peracchia, MT ;
Santi, P .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1996, 21 (02) :87-91
[45]   DEVELOPMENT OF ORAL LIQUID DOSAGE FORMS OF ACETAZOLAMIDE [J].
PARASRAMPURIA, J ;
DASGUPTA, V .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (09) :835-836
[46]   THE DEVELOPMENT OF ORAL LIQUID DOSAGE FORMS OF METRONIDAZOLE [J].
MATHEW, M ;
DASGUPTA, V ;
BETHEA, C .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1993, 18 (04) :291-294
[47]   Prilling of fatty acids as a continuous process for the development of controlled release multiparticulate dosage forms [J].
Vervaeck, A. ;
Saerens, L. ;
De Geest, B. G. ;
De Beer, T. ;
Carleer, R. ;
Adriaensens, P. ;
Remon, J. P. ;
Vervaet, C. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) :587-596
[48]   METHODS OF FOLLOWING DRUG RELEASE FROM CONTROLLED RELEASE DOSAGE FORMS [J].
GOULD, PL .
BRITISH POLYMER JOURNAL, 1983, 15 (04) :172-176
[49]   Immediate drug release from solid oral dosage forms [J].
Schreiner, T ;
Schaefer, UF ;
Loth, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (01) :120-133
[50]   Dissolution testing of oral modified-release dosage forms [J].
Garbacz, Grzegorz ;
Klein, Sandra .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (07) :944-968